Kymera Therapeutics Claimed Company
Kymera Therapeutics is a clinical stage biopharmaceutical company pioneering a transformative new modality, “targeted protein degradation” (TPD), with the ability to pursue targets long considered undruggable and to treat disease in entirely new ways. Our team has developed a proprietary drug discovery engine, Pegasus, to enable the design of highly selective, small molecule protein degraders with potent activity against a broad range of disease indications. We are committed to selecting targets with the broadest possible impact across multiple disease indications with high unmet medical need to realize the full potential of TPD. Kymera is led by an expert team of dedicated scientists and drug hunters, with decades of experience in the foundational areas of targeted protein degradation and drug development. read more
HR or Marketing? Claim Your Free Employer Account
Kymera Therapeutics Executive Salaries
Key Executives
Name
Title
Salary
Total Comp Total Compensation includes both short-term and long-term benefits, option grants, salary, bonuses, company perks, etc. that can be used to determine financial benefits. An executive may or may not realize all of the Total Co mpensation during their tenure at the Company. Values of the benefits may change over time.
The average Kymera Therapeutics executive compensation is $203,179 a year.The median estimated compensation for executives at Kymera Therapeutics including base salary and bonus is $201,452, or $96 per hour. At Kymera Therapeutics, the most compensated executive makes $950,000, annually, and the lowest compensated makes $34,000.
Last updated months ago.
$80k
$142k
$200k
$400k
$950k
$203,179*
Average Compensation
$201,452*
Median Compensation
* Estimated salaries Estimated salaries are based on data provided anonymously by employees and/or estimated by other statistical methods.
×